A translocation t(6;14) in two cases of leiomyosarcoma: Molecular cytogenetic and array-based comparative genomic hybridization characterization

Cancer Genetics

Volumn 208, Issue 11, 2015, Pages 537-544

  de Graaff, Marieke A ^a   de Jong, Daniëlle ^a   Briaire de Bruijn, Inge H ^a   Hogendoorn, Pancras C W ^a   Bovée, Judith V M G ^a   Szuhai, Károly ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Array CGH; FISH; HMGA1; Leiomyosarcoma; Soft tissue sarcoma; Translocation

Indexed keywords

ALPHA ACTININ 1; ACTININ; ACTN1 PROTEIN, HUMAN; HIGH MOBILITY GROUP A1A PROTEIN;

ACTN1 GENE; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 6P; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 6; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENE LOCUS; GENETIC ASSOCIATION; HMGA1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; LEIOMYOSARCOMA; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; SPINDLE CELL SARCOMA; UTERUS SARCOMA; CHROMOSOME 14; CHROMOSOME 6; GENE TRANSLOCATION; GENETICS; MUTATION; PATHOLOGY; PROCEDURES; TISSUE MICROARRAY; TUMOR CELL CULTURE;

ACTININ; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 6; COMPARATIVE GENOMIC HYBRIDIZATION; HMGA1A PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEIOMYOSARCOMA; MUTATION; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 84947863762     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2015.07.005     Document Type: Article

References (37)

1. Lazar A.J., Evans H.L., Shipley J. Smooth-muscle tumours. WHO Classification of Tumors of Soft Tissue and Bone 2013, 109-113. IARC, Lyon. C.D.M. Fletcher, J.A. Bridge, P.C.W. Hogendoorn (Eds.).
2. Italiano A., Lagarde P., Brulard C., et al. Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics. Clin Cancer Res 2013, 19:1190-1196.
3. Svarvar C., Bohling T., Berlin O., et al. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group. Cancer 2007, 109:282-291.
4. Gladdy R.A., Qin L.X., Moraco N., et al. Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol 2013, 20:1851-1857.
5. Radaelli S., Stacchiotti S., Casali P.G., et al. Emerging therapies for adult soft tissue sarcoma. Expert Rev Anticancer Ther 2014, 14:689-704.
6. Corless C.L., Barnett C.M., Heinrich M.C. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer 2011, 11:865-878.
7. Hirota S., Isozaki K., Moriyama Y., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998, 279:577-580.
8. Sandberg A.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet 2005, 161:1-19.
9. Szuhai K., Tanke H.J. COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping. Nat Protoc 2006, 1:264-275.
10. ISCN: An International System for Human Cytogenetic Nomenclature 2013, S. Karger, Basel. L.G. Shaffer, J. McGowan-Jordan, M. Schmid (Eds.).
11. de Graaff M.A., Cleton-Jansen A.M., Szuhai K., et al. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity. Hum Pathol 2013, 44:1597-1604.
12. Rossi S., Szuhai K., Ijszenga M., et al. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res 2007, 13:7322-7328.
13. Giuntoli R.L., Lessard-Anderson C.R., Gerardi M.A., et al. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma. Int J Gynecol Cancer 2013, 23:869-876.
14. D'Angelo E., Prat J. Uterine sarcomas: a review. Gynecol Oncol 2010, 116:131-139.
15. Dal Cin P., Quade B.J., Weremowicz S., et al. Primary parauterine leiomyoma with a t(6;14). Genes Chromosomes Cancer 1999, 26:385-386.
16. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 2001, 277:63-81.
17. Kazmierczak B., Pohnke Y., Bullerdiek J. Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics 1996, 38:223-226.
18. Rawlinson N.J., West W.W., Nelson M., et al. Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature. Cancer Genet Cytogenet 2008, 181:119-124.
19. Petit M.M., Schoenmakers E.F., Huysmans C., et al. LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 1999, 57:438-441.
20. Kazmierczak B., Dal Cin P., Wanschura S., et al. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 1998, 23:279-285.
21. Nucci M.R., Drapkin R., Dal Cin P., et al. Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications. Am J Surg Pathol 2007, 31:737-743.
22. Bowen J.M., Cates J.M., Kash S., et al. Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet 2012, 205:249-254.
23. Hui P., Li N., Johnson C., et al. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor. Mod Pathol 2005, 18:1519-1526.
24. Reeves R. Nuclear functions of the HMG proteins. Biochim Biophys Acta 2010, 1799:3-14.
25. Fedele M., Pierantoni G.M., Berlingieri M.T., et al. Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res 2001, 61:4583-4590.
26. Wood L.J., Mukherjee M., Dolde C.E., et al. HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol Cell Biol 2000, 20:5490-5502.
27. Nord K.H., Lilljebjörn H., Vezzi F., et al. GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma. Nat Genet 2014, 46:474-477.
28. Sjöblom B., Salmazo A., Djinovic-Carugo K. Alpha-actinin structure and regulation. Cell Mol Life Sci 2008, 65:2688-2701.
29. Schoenmakers E.F., Huysmans C., Van de Ven W.J. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 1999, 59:19-23.
30. Schoenmakers E.F., Bunt J., Hermers L., et al. Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma. Genes Chromosomes Cancer 2013, 52:11-23.
31. Amant F., Debiec-Rychter M., Schoenmakers E.F., et al. Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome. Genes Chromosomes Cancer 2001, 32:324-329.
32. Agaram N.P., Sung Y.S., Zhang L., et al. Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol 2015, 39:813-825.
33. Mitelman F., Johansson B., Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer Available at, Accessed 29 June, 2015. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
34. Stephens P.J., Greenman C.D., Fu B., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40.
35. Mehine M., Kaasinen E., Makinen N., et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 2013, 369:43-53.
36. Perot G., Derre J., Coindre J.M., et al. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. Cancer Res 2009, 69:2269-2278.
37. Wang Y., Marino-Enriquez A., Bennett R.R., et al. Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nat Genet 2014, 46:601-606.